Scientech Research LLC’s Quest Diagnostics DGX Stock Holding History

Scientech Research LLC’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,278	Closed	-$395K	–	540
2025 Q4	$395K	Buy	+2,278	New	+$415K	0.25%	131
2025 Q2	–	Sell	-2,566	Closed	-$434K	–	651
2025 Q1	$434K	Buy	2,566 +282	+12%	+$46.3K	0.11%	356
2024 Q4	$345K	Buy	+2,284	New	+$355K	0.1%	389
2024 Q3	–	Sell	-6,437	Closed	-$881K	–	667
2024 Q2	$881K	Buy	+6,437	New	+$882K	0.18%	200

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Scientech Research LLC's DGX Position: Q1 2026 in Review

Scientech Research LLC sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 2,278 shares — an estimated $395K sold.

Scientech Research LLC first reported a position in DGX in Q2 2024 and held it in 4 quarters. The position peaked at $881K in Q2 2024. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Scientech Research LLC reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Scientech Research LLC sold 2,278 Quest Diagnostics shares in Q1 2026, an estimated $395K.
Scientech Research LLC first reported a position in Quest Diagnostics in Q2 2024 and held it in 4 quarters.
Scientech Research LLC's Quest Diagnostics position peaked at $881K in Q2 2024.
1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.